Works matching IS 00070920 AND DT 2022 AND VI 126 AND IP 12

Results: 18
    1
    2

    Checkpoint inhibitors in a marriage: consented or arranged?

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1834, doi. 10.1038/s41416-022-01820-8
    By:
    • Brest, Patrick;
    • Refae, Sadal;
    • Mograbi, Baharia;
    • Ferrero, Jean-Marc;
    • Bontoux, Christophe;
    • Hofman, Paul;
    • Milano, Gerard
    Publication type:
    Article
    3

    Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1774, doi. 10.1038/s41416-022-01752-3
    By:
    • Cabasag, Citadel J.;
    • Arnold, Melina;
    • Rutherford, Mark;
    • Bardot, Aude;
    • Ferlay, Jacques;
    • Morgan, Eileen;
    • Little, Alana;
    • De, Prithwish;
    • Dixon, Elijah;
    • Woods, Ryan R.;
    • Saint-Jacques, Nathalie;
    • Evans, Sue;
    • Engholm, Gerda;
    • Elwood, Mark;
    • Merrett, Neil;
    • Ransom, David;
    • O'Connell, Dianne L.;
    • Bray, Freddie;
    • Soerjomataram, Isabelle
    Publication type:
    Article
    4

    Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1755, doi. 10.1038/s41416-022-01750-5
    By:
    • Dalmartello, Michela;
    • Turati, Federica;
    • Zhang, Zuo-Feng;
    • Lunet, Nuno;
    • Rota, Matteo;
    • Bonzi, Rossella;
    • Galeone, Carlotta;
    • Martimianaki, Georgia;
    • Palli, Domenico;
    • Ferraroni, Monica;
    • Yu, Guo-Pei;
    • Morais, Samantha;
    • Malekzadeh, Reza;
    • López-Carrillo, Lizbeth;
    • Zaridze, David;
    • Maximovitch, Dmitry;
    • Aragonés, Nuria;
    • Fernández-Tardón, Guillermo;
    • Martin, Vicente;
    • Vioque, Jesus
    Publication type:
    Article
    5
    6
    7
    8
    9

    Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1824, doi. 10.1038/s41416-022-01742-5
    By:
    • Laoukili, Jamila;
    • Constantinides, Alexander;
    • Wassenaar, Emma C. E.;
    • Elias, Sjoerd G.;
    • Raats, Danielle A. E.;
    • van Schelven, Susanne J.;
    • van Wettum, Jonathan;
    • Volckmann, Richard;
    • Koster, Jan;
    • Huitema, Alwin D. R.;
    • Nienhuijs, Simon W.;
    • de Hingh, Ignace H. J. T.;
    • Wiezer, René J.;
    • van Grevenstein, Helma M. U.;
    • Rinkes, Inne H. M. Borel;
    • Boerma, Djamila;
    • Kranenburg, Onno
    Publication type:
    Article
    10

    HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1783, doi. 10.1038/s41416-022-01738-1
    By:
    • Loi, Eleonora;
    • Zavattari, Cesare;
    • Tommasi, Alessandro;
    • Moi, Loredana;
    • Canale, Matteo;
    • Po, Agnese;
    • Sabato, Claudia;
    • Vega-Benedetti, Ana Florencia;
    • Ziranu, Pina;
    • Puzzoni, Marco;
    • Lai, Eleonora;
    • Faloppi, Luca;
    • Rullán, María;
    • Carrascosa, Juan;
    • Amat, Irene;
    • Urman, Jesús M.;
    • Arechederra, Maria;
    • Berasain, Carmen;
    • Ferretti, Elisabetta;
    • Casadei-Gardini, Andrea
    Publication type:
    Article
    11
    12
    13
    14
    15

    Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1695, doi. 10.1038/s41416-022-01717-6
    By:
    • Roque, Dana M.;
    • Siegel, Eric R.;
    • Buza, Natalia;
    • Bellone, Stefania;
    • Silasi, Dan-Arin;
    • Huang, Gloria S.;
    • Andikyan, Vaagn;
    • Clark, Mitchell;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Rao, Gautam G.;
    • Reader, Jocelyn C.;
    • Hui, Pei;
    • Tymon-Rosario, Joan R.;
    • Harold, Justin;
    • Mauricio, Dennis;
    • Zeybek, Burak;
    • Menderes, Gulden;
    • Altwerger, Gary;
    • Ratner, Elena
    Publication type:
    Article
    16
    17

    The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1715, doi. 10.1038/s41416-021-01690-6
    By:
    • de Gregorio, Amelie;
    • Janni, Wolfgang;
    • Friedl, Thomas W. P.;
    • Nitz, Ulrike;
    • Rack, Brigitte;
    • Schneeweiss, Andreas;
    • Kates, Ronald;
    • Fehm, Tanja;
    • Kreipe, Hans;
    • Christgen, Matthias;
    • Kümmel, Sherko;
    • Trapp, Elisabeth;
    • Wuerstlein, Rachel;
    • Hartkopf, Andreas;
    • Clemens, Michael;
    • Reimer, Toralf;
    • Häberle, Lothar;
    • Fasching, Peter A.;
    • Gluz, Oleg;
    • Harbeck, Nadia
    Publication type:
    Article
    18

    Comprehensive screening for drugs that modify radiation-induced immune responses.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 12, p. 1815, doi. 10.1038/s41416-021-01688-0
    By:
    • Okumura, Masayuki;
    • Du, Junyan;
    • Kageyama, Shun-Ichiro;
    • Yamashita, Riu;
    • Hakozaki, Yumi;
    • Motegi, Atsushi;
    • Hojo, Hidehiro;
    • Nakamura, Masaki;
    • Hirano, Yasuhiro;
    • Okuma, Yusuke;
    • Okuma, Hitomi S.;
    • Tsuchihara, Katsuya;
    • Akimoto, Tetsuo
    Publication type:
    Article